Future destinations and social inclusion scoping review: how people cured of hepatitis C (HCV) using direct- acting antiviral drugs progress in a new HCV-free world
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1747-597X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Future destinations and social inclusion scoping review: how people cured of hepatitis C (HCV) using direct- acting antiviral drugs progress in a new HCV-free world ; volume:17 ; number:1 ; day:8 ; month:6 ; year:2022 ; pages:1-10 ; date:12.2022
Substance abuse treatment, prevention, and policy ; 17, Heft 1 (8.6.2022), 1-10, 12.2022
- Creator
-
Donaldson, Sarah R.
Radley, Andrew
Dillon, John F.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13011-022-00475-1
- URN
-
urn:nbn:de:101:1-2022080522234204667046
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Donaldson, Sarah R.
- Radley, Andrew
- Dillon, John F.
- SpringerLink (Online service)
Other Objects (12)
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)
HCV
Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
Changes in tryptophan and phenylalanine in chronic HCV patients treated with direct acting antiviral (sofosbuvir)
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
Utility of the new cobas HCV test for viral load monitoring during direct-acting antiviral therapy
Direct-acting antiviral therapy may help restore HCV-induced impaired redox balance and liver fibrosis process
Effect of direct-acting antiviral drugs on portal circulation hemodynamics in cirrhotic patients infected with HCV
Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation
Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)
HCV
Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
Changes in tryptophan and phenylalanine in chronic HCV patients treated with direct acting antiviral (sofosbuvir)
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
Utility of the new cobas HCV test for viral load monitoring during direct-acting antiviral therapy
Direct-acting antiviral therapy may help restore HCV-induced impaired redox balance and liver fibrosis process
Effect of direct-acting antiviral drugs on portal circulation hemodynamics in cirrhotic patients infected with HCV
Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation
Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)
HCV
Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
Changes in tryptophan and phenylalanine in chronic HCV patients treated with direct acting antiviral (sofosbuvir)
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
Utility of the new cobas HCV test for viral load monitoring during direct-acting antiviral therapy
Direct-acting antiviral therapy may help restore HCV-induced impaired redox balance and liver fibrosis process
Effect of direct-acting antiviral drugs on portal circulation hemodynamics in cirrhotic patients infected with HCV
Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation
Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation